IP Verse

Syringe

Patent No. EP3777834 (titled "Syringe") was filed by Novartis on May 30, 2013. The application was issued on Feb 16, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HAMM & WITTKOPPNov 16, 2022HAMM & WITTKOPP
WESSNov 16, 2022SSM SANDMAIR
EHLERSNov 15, 2022EISENFUHR SPEISER
STRAWMANNov 15, 2022HOFFMANN EITLE
KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBBNov 14, 2022KEIL & SCHAAFHAUSEN PATENTANWALTE PARTGMBB
TEVA PHARMACEUTICALSNov 4, 2022ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3777834

NOVARTIS
Application Number
EP20198921A
Filing Date
May 30, 2013
Status
Granted And Under Opposition
Jan 14, 2022
Publication Date
Feb 16, 2022
External Links
Slate, Register , Google Patents